Preclinical Characterization Of Fm101, A First-In-Class A3 Adenosine Receptor Modulator For The Treatment Of Non-Alcoholic SteatohepatitisChangho Shon,Su-Yeon Choi,Jeong-Su Park,Chong-Woo Park,Jiyoun Lee,Yoon-Seok RohJOURNAL OF HEPATOLOGY（2019）引用 2|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
